The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Presenilin mutations linked to familial Alzheimer's disease cause an imbalance in phosphatidylinositol 4,5-bisphosphate metabolism
Open accessAbstract
Phosphatidylinositol 4,5-bisphosphate (PIP 2 ) is an important cellular effector whose functions include the regulation of ion channels and membrane trafficking. Aberrant PIP 2 metabolism has also been implicated in a variety of human disease states, e.g., cancer and diabetes. Here we report that familial Alzheimer's disease (FAD)-associated presenilin mutations cause an imbalance in PIP 2 metabolism. We find that the transient receptor potential melastatin 7 (TRPM7)-associated Mg 2+ -inhibited cation (MIC) channel underlies ion channel dysfunction in presenilin FAD mutant cells, and the observed channel deficits are restored by the addition of PIP 2 , a known regulator of the MIC/TRPM7 channel. Lipid analyses show that PIP 2 turnover is selectively affected in FAD mutant presenilin cells. We also find that modulation of cellular PIP 2 closely correlates with 42-residue amyloid β-peptide (Aβ42) levels. Our data suggest that PIP 2 imbalance may contribute to Alzheimer's disease pathogenesis by affecting multiple cellular pathways, such as the generation of toxic Aβ42 as well as the activity of the MIC/TRPM7 channel, which has been linked to other neurodegenerative conditions. Thus, our study suggests that brain-specific modulation of PIP 2 may offer a therapeutic approach in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Familial AD PSEN1 mutations result in disrupted metabolism of PI(4,5)P2 [95] and PI(4,5)P2 has been reported to be reduced in the AD brain [93].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [95]
The cited source says what the claim attributes to it.
In the citing paper
“Altered PI(4,5)P2 metabolism has been linked to Aβ toxicity [93–95].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [95]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The C-terminus of SHIP1 contains a NPxY motif, which can bind to proteins containing immunoreceptor tyrosine inhibitory motifs (ITIM)/immunoreceptor tyrosine activating motifs (ITAM), phosphotyrosine-binding (PTB) or SH2 domains, as well as a proline-rich PxxP motif that contains SH3-binding domains [47, 93–98] (Fig. 2).”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [95]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Store-Operated Calcium Channels
Parekh, A. B., & Putney, J. W. (2005) · Physiological Reviews · doi:10.1152/physrev.00057.2003 · Cited by 2,089
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain
Schroeter, E. H., Kisslinger, J. A., & Kopan, R. (1998) · Nature · doi:10.1038/30756 · Cited by 1,624
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1
Li, Y.-M., Xu, M., Lai, M.-T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. G., et al. (2000) · Nature · doi:10.1038/35015085 · Cited by 866
Cited by
Sorted by citations
Linking lipids to Alzheimer's disease: cholesterol and beyond
Di Paolo, G., & Kim, T.-W. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3012 · Cited by 972
Self-citationPresenilins Are Enriched in Endoplasmic Reticulum Membranes Associated with Mitochondria
Area-Gomez, E., de Groof, A. J. C., Boldogh, I., Bird, T. D., Gibson, G. E., Koehler, C. M., Yu, W. H., Duff, K. E., Yaffe, M. P., Pon, L. A., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090219 · Cited by 369
Brain lipidomics: From functional landscape to clinical significance
Yoon, J. H., Seo, Y., Jo, Y. S., Lee, S., Cho, E., Cazenave-Gassiot, A., Shin, Y.-S., Moon, M. H., An, H. J., Wenk, M. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9317 · Cited by 324
Wunderlich, P., Glebov, K., Kemmerling, N., Tien, N. T., Neumann, H., & Walter, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517540 · Cited by 296
Understanding phosphoinositides: rare, dynamic, and essential membrane phospholipids
Dickson, E. J., & Hille, B. (2019) · Biochemical Journal · doi:10.1042/bcj20180022 · Cited by 254
Morel, E., Chamoun, Z., Lasiecka, Z. M., Chan, R. B., Williamson, R. L., Vetanovetz, C., Dall’Armi, C., Simoes, S., Point Du Jour, K. S., McCabe, B. D., et al. (2013) · Nature Communications · doi:10.1038/ncomms3250 · Cited by 222
Li, R.-Y., Qin, Q., Yang, H.-C., Wang, Y.-Y., Mi, Y.-X., Yin, Y.-S., Wang, M., Yu, C.-J., & Tang, Y. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00542-y · Cited by 204
Calcium dysregulation in Alzheimer's disease
Bojarski, Ł., Herms, J. W., & Kuźnicki, J. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.10.002 · Cited by 207
Fukami, K., Inanobe, S., Kanemaru, K., & Nakamura, Y. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.06.001 · Cited by 197
Bourdenx, M., Koulakiotis, N. S., Sanoudou, D., Bézard, E., Dehay, B., & Tsarbopoulos, A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.003 · Cited by 202
Oligomeric amyloid-β peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism
Berman, D. E., Dall'Armi, C., Voronov, S. V., McIntire, L. B. J., Zhang, H., Moore, A. Z., Staniszewski, A., Arancio, O., Kim, T.-W., & Di Paolo, G. (2008) · Nature Neuroscience · doi:10.1038/nn.2100 · Cited by 199
Self-citationSantoni, G., Cardinali, C., Morelli, M. B., Santoni, M., Nabissi, M., & Amantini, C. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0239-2 · Cited by 182
Voronov, S. V., Frere, S. G., Giovedi, S., Pollina, E. A., Borel, C., Zhang, H., Schmidt, C., Akeson, E. C., Wenk, M. R., Cimasoni, L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803756105 · Cited by 174
Self-citationSphingolipids: Critical players in Alzheimer’s disease
van Echten‐Deckert, G., & Walter, J. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.07.001 · Cited by 171
Zhu, L., Zhong, M., Elder, G. A., Sano, M., Holtzman, D. M., Gandy, S., Cardozo, C., Haroutunian, V., Robakis, N. K., & Cai, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510011112 · Cited by 160
Nazıroğlu, M., Dikici, D. M., & Dursun, Ş. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0850-x · Cited by 141
Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis
Dong, S., Duan, Y., Hu, Y., & Zhao, Z. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-18 · Cited by 147
X-ray Crystal Structure of a TRPM Assembly Domain Reveals an Antiparallel Four-stranded Coiled-coil
Fujiwara, Y., & Minor, D. L. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.059 · Cited by 122
Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene
Bagaria, J., Bagyinszky, E., & An, S. S. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810970 · Cited by 125
X-ray Crystal Structure Of A Trpm Assembly Domain Reveals An Antiparallel Four-stranded Coiled-coil
Fujiwara, Y., & Minor, D. L. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.12.2923 · Cited by 109
BACE1 Retrograde Trafficking Is Uniquely Regulated by the Cytoplasmic Domain of Sortilin
Finan, G. M., Okada, H., & Kim, T.-W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.170217 · Cited by 104
Self-citationPhosphatidylinositol 4,5‐bisphosphate: Targeted production and signaling
Sun, Y., Thapa, N., Hedman, A. C., & Anderson, R. A. (2013) · BioEssays · doi:10.1002/bies.201200171 · Cited by 114
Proteomic identification of sorting nexin 6 as a negative regulator of BACE1‐mediated APP processing
Okada, H., Zhang, W., Peterhoff, C., Hwang, J. C., Nixon, R. A., Ryu, S. H., & Kim, T. (2010) · The FASEB Journal · doi:10.1096/fj.09-146357 · Cited by 102
Self-citationCossec, J., Lavaur, J., Berman, D. E., Rivals, I., Hoischen, A., Stora, S., Ripoll, C., Mircher, C., Grattau, Y., Olivo‐Marín, J., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds142 · Cited by 106
Phospholipase D in brain function and Alzheimer's disease
Oliveira, T. G., & Paolo, G. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.04.004 · Cited by 99
Terzioglu, G., & Young-Pearse, T. L. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00674-9 · Cited by 91
Dysregulation of Calcium Homeostasis in Alzheimer’s Disease
Small, D. H. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9960-5 · Cited by 96
TRPM7 and TRPM2—Candidate susceptibility genes for Western Pacific ALS and PD?
Hermosura, M. C., & Garruto, R. M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.02.008 · Cited by 94
Phospholipase C families: Common themes and versatility in physiology and pathology
Katan, M., & Cockcroft, S. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101065 · Cited by 89
TRPM7: A unique channel involved in magnesium homeostasis
Paravicini, T. M., Chubanov, V., & Gudermann, T. W. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.010 · Cited by 86
Uddin, M. S., Kabir, M. T., Tewari, D., Mathew, B., & Aleya, L. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.134836 · Cited by 83
Bennett, S. A. L., Valenzuela, N., Xu, H., Franko, B., Fai, S., & Figeys, D. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00168 · Cited by 89
TRPM7, the Mg2+ Inhibited Channel and Kinase
Bates-Withers, C., Sah, R., & Clapham, D. E. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0265-3_9 · Cited by 83
Tseveleki, V., Rubio, R., Vamvakas, S. M., White, J., Taoufik, E., Petit, E., Quackenbush, J. F., & Probert, L. (2010) · Genomics · doi:10.1016/j.ygeno.2010.04.004 · Cited by 86
TRPM7 and its role in neurodegenerative diseases
Sun, Y., Sukumaran, P., Schaar, A., & Singh, B. B. (2015) · Channels · doi:10.1080/19336950.2015.1075675 · Cited by 82
Lipids as central modulators of sensory TRP channels
Ciardo, M. G., & Ferrer-Montiel, A. V. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.04.012 · Cited by 81
TRP Channels Role in Pain Associated With Neurodegenerative Diseases
Duitama, M., Vargas-López, V., Casas, Z., Albarracín, S. L., Sutachan, J. J., & Torres, Y. P. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00782 · Cited by 80
Cross-talk of membrane lipids and Alzheimer-related proteins
Walter, J., & van Echten‐Deckert, G. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-34 · Cited by 79
The Role of Aβ-Induced Calcium Dysregulation in the Pathogenesis of Alzheimer's Disease
Small, D. H., Gasperini, R., Vincent, A. J., Hung, A. C., & Foa, L. C. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0951 · Cited by 77
McIntire, L. B., Berman, D. E., Myaeng, J., Staniszewski, A., Arancio, O., Paolo, G. D., & Kim, T. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2034-12.2012 · Cited by 78
Self-citationFunction and regulation of the channel-kinase TRPM7 in health and disease
Visser, D., Middelbeek, J., van Leeuwen, F. N., & Jalink, K. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.07.001 · Cited by 82
PIP2 Improves Cerebral Blood Flow in a Mouse Model of Alzheimer’s Disease
Mughal, A., Harraz, O. F., Gonzales, A. L., Hill‐Eubanks, D. C., & Nelson, M. T. (2021) · Function · doi:10.1093/function/zqab010 · Cited by 71
Skwarek, L. C., & Boulianne, G. L. (2009) · Developmental Cell · doi:10.1016/j.devcel.2008.12.006 · Cited by 72
Zhu, L., Zhong, M., Zhao, J., Rhee, H., Caesar, I., Knight, E. M., Volpicelli-Daley, L., Bustos, V., Netzer, W., Liu, L., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.504365 · Cited by 70
Alzheimer’s Disease Risk Genes and Lipid Regulators
Gaamouch, F. E., Jing, P., Xia, J., & Cai, D. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160169 · Cited by 67
The Involvement of Lipids in Alzheimer's Disease
Lim, W. L. F., Martins, I. J., & Martins, R. N. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.04.003 · Cited by 67
Cao, Y., Zhao, L.-W., Chen, Z.-X., & Li, S.-H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 65
Drouet, V., & Lesage, S. (2014) · BioMed Research International · doi:10.1155/2014/289728 · Cited by 66
Turlova, E., Wong, R., Xu, B., Li, F., Du, L., Habbous, S., Horgen, F. D., Fleig, A., Feng, Z., & Sun, H. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00810-3 · Cited by 59
Low hippocampal PI(4,5)P2 contributes to reduced cognition in old mice as a result of loss of MARCKS
Trovò, L., Ahmed, T., Callaerts‐Vegh, Z., Buzzi, A., Bagni, C., Chuah, M., VandenDriessche, T., D’Hooge, R., Balschun, D., & Dotti, C. G. (2013) · Nature Neuroscience · doi:10.1038/nn.3342 · Cited by 61
Discovery of Candidate Genes for Muscle Traits Based on GWAS Supported by eQTL-analysis
Ponsuksili, S., Muráni, E., Trakooljul, N., Schwerin, M., & Wimmers, K. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8134 · Cited by 63
Lachén‐Montes, M., González-Morales, A., de Morentin, X. M., Pérez‐Valderrama, E., Ausín, K., Zelaya, M. V., Serna, A., Aso, E., Ferrer, I., Fernández‐Irigoyen, J., et al. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.07.032 · Cited by 61
Zeng, Z., Leng, T., Feng, X., Sun, H., Inoue, K., Zhu, L., & Xiong, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119912 · Cited by 58
Volpicelli-Daley, L. A., Lucast, L., Gong, L.-W., Liu, L., Sasaki, J., Sasaki, T., Abrams, C. S., Kanaho, Y., & De Camilli, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.132191 · Cited by 57
Waugh, M. G. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.02.002 · Cited by 59
Miranda, A. M., Herman, M., Cheng, R., Nahmani, E., Barrett, G., Micevska, E., Fontaine, G., Potier, M., Head, E., Schmitt, F. A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.011 · Cited by 57
Li, J., Gao, Z., Zhao, D., Zhang, L., Qiao, X., Zhao, Y., Ding, H., Zhang, P., Lu, J., Liu, J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0484 · Cited by 53
Cho, Y. Y., Kwon, O.-H., Park, M. K., Kim, T.-W., & Chung, S. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210535 · Cited by 48
Self-citationPan, P., Sheehan, P., Wang, Q., Zhu, X., Zhang, Y., Choi, I., Li, X., Saenz, J., Zhu, J., Wang, J., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa080 · Cited by 52
Lipidomics of Alzheimer’s Disease
Touboul, D., & Gaudin, M. (2014) · Bioanalysis · doi:10.4155/bio.13.346 · Cited by 52
Kim, J., Kim, S. H., Lee, D.-S., Lee, D., Kim, S.-H., Chung, S., & Yang, H. O. (2013) · Journal of Ginseng Research · doi:10.5142/jgr.2013.37.100 · Cited by 52
Self-citationPlasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study
Chatterjee, P., Lim, W. L. F., Shui, G., Gupta, V. B., JAMES, I. R., Fagan, A. M., Xiong, C., Sohrabi, H. R., Taddei, K., Brown, B. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150948 · Cited by 49
Mendis, L. H. S., Grey, A. C., Faull, R. L. M., & Curtis, M. A. (2016) · Brain and Behavior · doi:10.1002/brb3.517 · Cited by 50
Role of Phosphoinositides at the Neuronal Synapse
Frère, S. G. A., Chang-Ileto, B., & Paolo, G. D. (2012) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-3015-1_5 · Cited by 48
Therapeutic potential of pharmacological agents targeting TRP channels in CNS disorders
Thapak, P., Vaidya, B., Joshi, H. C., Singh, J. N., & Sharma, S. S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105026 · Cited by 46
Cholesterol modulates ion channels via down‐regulation of phosphatidylinositol 4,5‐bisphosphate
Chun, Y. S., Shin, S., Kim, Y., Cho, H., Park, M. K., Kim, T., Voronov, S. V., Paolo, G. D., Suh, B., & Chung, S. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06545.x · Cited by 46
Self-citationPhosphoinositides Suppress γ-Secretase in Both the Detergent-soluble and -insoluble States
Osawa, S., Funamoto, S., Nobuhara, M., Wada‐Kakuda, S., Shimojo, M., Yagishita, S., & Ihara, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705954200 · Cited by 45
Kamermans, A., Planting, K. E., Jalink, K., van Horssen, J., & de Vries, H. E. (2018) · Glia · doi:10.1002/glia.23526 · Cited by 42
Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterolPreprint
Wang, H., Kulas, J. A., Ferris, H. A., & Hansen, S. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.18.159632 · Cited by 43
Kang, M. S., Baek, S., Chun, Y. S., Moore, A. Z., Landman, N., Berman, D. E., Yang, H. O., Morishima‐Kawashima, M., Osawa, S., Funamoto, S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445734 · Cited by 38
Self-citationLiu, X., Du, Y., Trakooljul, N., Brand, B., Muráni, E., Krischek, C., Wicke, M., Schwerin, M., Wimmers, K., & Ponsuksili, S. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.13132 · Cited by 38
Role of the chanzyme TRPM7 in the nervous system in health and disease
Abumaria, N., Li, W., & Clarkson, A. N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03124-2 · Cited by 37
Kawade, N., & Yamanaka, K. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13661 · Cited by 35
Endocytosis and Alzheimer’s disease
Zadka, Ł., Sochocka, M., Hachiya, N., Chojdak-Łukasiewicz, J., Dzięgiel, P., Piasecki, E., & Leszek, J. (2023) · GeroScience · doi:10.1007/s11357-023-00923-1 · Cited by 33
Mandal, M., & Yan, Z. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058701 · Cited by 30
Distribution and neuronal expression of phosphatidylinositol phosphate kinase IIγ in the mouse brain
Clarke, J. H., Emson, P. C., & Irvine, R. F. (2009) · The Journal of Comparative Neurology · doi:10.1002/cne.22161 · Cited by 30
Presenilins and the γ-secretase: still a complex problem
Small, D. H., Klaver, D. W., & Foa, L. C. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-7 · Cited by 29
Defining the minimum substrate and charge recognition model of gamma-secretase
Yan, Y., Xu, T.-H., Melcher, K., & Xu, H. E. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.35 · Cited by 30
Gosney, R., Liau, W., & LaMunyon, C. W. (2008) · BMC Developmental Biology · doi:10.1186/1471-213x-8-44 · Cited by 29
Gandy, S., Zhang, Y., Ikin, A. F., Schmidt, S. D., Levy, E., Sheffield, R., Nixon, R. A., Liao, F., Mathews, P. M., Xu, H., et al. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04587.x · Cited by 27
Su, R., Han, Z.-Y., Fan, J.-P., & Zhang, Y.-L. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-0131-0 · Cited by 27
Oh, H. G., & Chung, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.163 · Cited by 25
Self-citationMcKeever, P. M., Kim, T. P., Hesketh, A. R., MacNair, L., Miletic, D., Favrin, G., Oliver, S. G., Zhang, Z., George‐Hyslop, P. S., & Robertson, J. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.05.014 · Cited by 27
Self-citationMačianskienė, R., Gwanyanya, A., Vereecke, J., & Mubagwa, K. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000149788 · Cited by 23
Transient Receptor Potential (TRP) Channels in the Brain: the Good and the Ugly
Nilius, B. (2012) · European Review · doi:10.1017/s1062798711000597 · Cited by 23
Modulation of transient receptor potential melastatin related 7 channel by presenilins
Oh, H. G., Chun, Y. S., Kim, Y., Youn, S. H., Shin, S., Park, M. K., Kim, T., & Chung, S. (2011) · Developmental Neurobiology · doi:10.1002/dneu.22001 · Cited by 24
Self-citationWhat Do We Really Know and What Do We Need to Know: Some Controversies, Perspectives, and Surprises
Nilius, B., & Flockerzi, V. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-05161-1_20 · Cited by 22
Xing, J., & Strange, K. B. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00394.2009 · Cited by 23
Park, C. S., Lee, J. Y., Choi, H. Y., Ju, B. G., & Yune, T. Y. (2022) · Journal of Neurotrauma · doi:10.1089/neu.2021.0338 · Cited by 20
Zhang, S., Cao, F., Li, W., & Abumaria, N. (2023) · Science Signaling · doi:10.1126/scisignal.ade6325 · Cited by 20
TRPM7 contributes to pyroptosis and its involvement in status epilepticus
Tong, X., Tong, Y., Zheng, J., Shi, R., Liang, H., Li, M., Meng, Y., Shi, J., Zhao, D., Seehus, C. R., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03292-4 · Cited by 19
Phosphoinositides in Neuroexocytosis and Neuronal Diseases
Wen, P. J., Osborne, S. L., & Meunier, F. A. (2012) · Current topics in microbiology and immunology · doi:10.1007/978-94-007-5025-8_4 · Cited by 19
PIP2: a new key player in Alzheimer's disease.
Arancio, O. (2008) · PubMed · Cited by 18
PIP 2 corrects an endothelial Piezo1 channelopathy
Hashad, A. M., Abd-Alhaseeb, M. M., Lim, X. R., Mathieu, N. M., & Harraz, O. F. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2522750122 · Cited by 16
Importance of γ-secretase in the regulation of liver X receptor and cellular lipid metabolism
Gutierrez, E., Lütjohann, D., Kerksiek, A., Fabiano, M., Oikawa, N., Kuerschner, L., Thiele, C., & Walter, J. (2020) · Life Science Alliance · doi:10.26508/lsa.201900521 · Cited by 15
Majid, H., Kohli, S., Islam, S. U., & Nidhi (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01597-6 · Cited by 13
Lee, S.-H., Lin, C., Chen, T., Chou, C. C. ‐., Chiu, M., Tee, B. L., Liang, H., & Cheng, T. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156456 · Cited by 15
Zhang, X., Wang, W.-A., Jiang, L.-X., Liu, H., Zhang, B., Lim, N. K.-H., Li, Q.-Y., & Huang, F.-D. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3567-16.2017 · Cited by 14
Altmann, S., Muráni, E., Metges, C. C., Schwerin, M., Wimmers, K., & Ponsuksili, S. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1541-z · Cited by 12
α-Synuclein-dependent increases in PIP5K1γ drive inositol signaling to promote neurotoxicity
Horvath, J. D., Casas, M., Kutchukian, C., Sánchez, S. C., Pergande, M. R., Cologna, S. M., Simó, S., Dixon, R. E., & Dickson, E. J. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113244 · Cited by 11
Metadata
- Authors
- Landman, N., Jeong, S. Y., Shin, S. Y., Voronov, S. V., Serban, G., Kang, M. S., Park, M. K., Di Paolo, G., Chung, S., & Kim, T.-W.
- Affiliations
- Columbia University Irving Medical Center (US)
- Sungkyunkwan University (KR)
- Department of Pathology, and
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-12-19
- Volume
- 103
- Issue
- 51
- Pages
- 19524-19529
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1748258
- OpenAlex
- W2047442659
- Cited by
- 149
- References
- 50
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 5 · 2023: 10 · 2022: 6 · 2021: 1 · 2020: 12 · 2019: 6 · 2018: 3 · 2017: 8 · 2016: 5 · 2015: 8 · 2014: 9 · 2013: 14 · 2012: 13
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ellison Medical Foundation
- National Institutes of Health
- Samsung
- National Institute of Neurological Disorders and Stroke (R01NS043467, F31NS051186, NS43467, NS51186)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD047733, R21HD047733)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Keywords
- presenilin mutations, familial Alzheimer's disease, phosphatidylinositol 4,5-bisphosphate, TRPM7, ion channel dysfunction, amyloid-beta 42, lipid turnover, Alzheimer's disease pathogenesis, therapeutic target
- MeSH terms
- Alzheimer Disease, Cell Line, Electrophysiology, Humans, Mutation, Phosphorylation, Blotting, Western, Amyloid beta-Peptides, Protein Serine-Threonine Kinases, Phosphotransferases (Alcohol Group Acceptor), TRPM Cation Channels, Presenilins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review